T CELLS/CYTOKINES FOR B CELL RESPONSES IN ORAL DISEASE
T 细胞/细胞因子对口腔疾病中 B 细胞的反应
基本信息
- 批准号:6296244
- 负责人:
- 金额:$ 4.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte Bacteroides gingivalis antibody formation bacterial antigens bactericidal immunity cytokine enzyme linked immunosorbent assay fibroblasts flow cytometry gene rearrangement gingiva helper T lymphocyte human tissue immunoglobulin genes immunopathology in situ hybridization inflammation interferon gamma interleukin 2 interleukin 4 interleukin 5 interleukin 6 laboratory mouse lymphocyte proliferation molecular cloning monocyte oral bacteria periodontium disorder polymerase chain reaction stress proteins superantigens tissue /cell culture
项目摘要
Our past work on this grant directly addressed immune aspects of
Periodontal Disease (PD) by development of methods for isolation of
gingival mononuclear cells (GMC) from the disease site. We have shown
that large numbers of immunoglobulin (Ig) secreting, spot forming cells
(SFC) occur, which are mainly restricted to IgG-subclass
(IgG1>IgG2>IgG3=IgG4) and less so to IgA-subclass (IgA1>IgA2) responses.
This unique system has allowed us to determine the degree of antigen-
specific SFC responses in PD, and we showed that Porphyromonas gingivalis
fimbriae and LPS are major and minor components of these IgG- and IgA-
subclass responses, respectively. Thus, our work suggests that the
predominant IgG- and IgA-plasma cell responses seen in PD have both
polyclonal and antigen-specific components. This has logically led to
an analysis of cytokines present in GMC supernatants (sups), which would
account for these unique profiles of B cell responses. Our studies have
now shown that IL-6 is a major terminal differentiation factor in GMC
sups, together with IL-5. Of importance to this proposal is the presence
of a potentially novel cytokine which induces IL-6 receptor (IL-6R)
expression on human lymphocytes. We plan to continue these exciting
studies by addressing the precise pattern of cytokines present in
individual cell types in GMC which account for B cell and plasma cell
responses. We will focus on IL-2, IL-4, IL-5, IL-6 and IFN-gamma and use
both PCR and in situ hybridization for these cytokines in both immune (T
helper (Th) cells subsets, B cells, monocytes/macrophages) and nonimmune
(fibroblasts and epithelial cells) cells from tissues of patients with
PD. Our preliminary studies suggest that gingival Th cells may be
induced, in part, by the presence of P. gingivalis fimbriae acting as a
superantigen and by heat shock proteins (hsps). We plan to assess CD4+
Th cells from GMC for responses to these antigens and to determine if
hsps induce Th1-type (IFN-gamma and IL-2) and fimbriae (superantigen)
elicits mainly Th2 (IL-4, IL-5 and IL-6) responses. By specific
derivation of cloned CD4+ Th cells, we can determine the relative
contribution of Th1 and Th2 cells for inflammation and B cell responses,
respectively. The potential role of TGF-beta and IL-4 in switches to
IgG- and IgA-subclasses will be addressed. We will determine if the IL-
6R inducing factor is a novel cytokine, and if so, we will purify and
clone this factor in order to evaluate its role in B cell responses.
Finally, we plan to determine the relative contribution of antigen-
specific T cells and derived cytokines for B cell responses, with
emphasis on fimbriae and hsps. this comprehensive analysis of Th cells
and cytokines will provide the cellular and molecular basis for B cell
responses in human PD and may be of predictive importance in
classification of the different forms of this disease.
我们过去的研究直接涉及免疫方面的问题
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIROSHI KIYONO其他文献
HIROSHI KIYONO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIROSHI KIYONO', 18)}}的其他基金
T CELLS/CYTOKINES FOR B CELL RESPONSES IN ORAL DISEASE
T 细胞/细胞因子对口腔疾病中 B 细胞的反应
- 批准号:
6104728 - 财政年份:1998
- 资助金额:
$ 4.21万 - 项目类别:
T CELLS/CYTOKINES FOR B CELL RESPONSES IN ORAL DISEASE
T 细胞/细胞因子对口腔疾病中 B 细胞的反应
- 批准号:
6270278 - 财政年份:1997
- 资助金额:
$ 4.21万 - 项目类别:
T CELLS/CYTOKINES FOR B CELL RESPONSES IN ORAL DISEASE
T 细胞/细胞因子对口腔疾病中 B 细胞的反应
- 批准号:
6238398 - 财政年份:1996
- 资助金额:
$ 4.21万 - 项目类别:
MOLECULAR EVASION OF ORAL TOLERANCE FOR MUCOSAL VACCINES
粘膜疫苗口服耐受性的分子规避
- 批准号:
2071908 - 财政年份:1994
- 资助金额:
$ 4.21万 - 项目类别:
MOLECULAR EVASION OF ORAL TOLERANCE FOR MCCOSAL VACCINES
MCCOSAL 疫苗口服耐受性的分子规避
- 批准号:
2330414 - 财政年份:1994
- 资助金额:
$ 4.21万 - 项目类别:
MOLECULAR EVASION OF ORAL TOLERANCE FOR MCCOSAL VACCINES
MCCOSAL 疫苗口服耐受性的分子规避
- 批准号:
2071910 - 财政年份:1994
- 资助金额:
$ 4.21万 - 项目类别:
MOLECULAR EVASION OF ORAL TOLERANCE FOR MCCOSAL VACCINES
MCCOSAL 疫苗口服耐受性的分子规避
- 批准号:
2653847 - 财政年份:1994
- 资助金额:
$ 4.21万 - 项目类别:
MOLECULAR EVASION OF ORAL TOLERANCE FOR MCCOSAL VACCINES
MCCOSAL 疫苗口服耐受性的分子规避
- 批准号:
2071909 - 财政年份:1994
- 资助金额:
$ 4.21万 - 项目类别:
相似海外基金
BSL-3 EMERGING PATHOGENS RES FACIL: ORAL BACTEROIDES, GINGIVALIS
BSL-3 新发病原体研究工具:口腔拟杆菌、牙龈杆菌
- 批准号:
7153803 - 财政年份:2005
- 资助金额:
$ 4.21万 - 项目类别: